HOUSE DOCKET, NO. 2198        FILED ON: 2/18/2011

HOUSE  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  No. 3364

 

The Commonwealth of Massachusetts

_________________

PRESENTED BY:

Thomas A. Golden, Jr.

_________________

To the Honorable Senate and House of Representatives of the Commonwealth of Massachusetts in General
Court assembled:

The undersigned legislators and/or citizens respectfully petition for the adoption of the accompanying resolve:

Resolve An Act relative to responsible prescription prescribing.

_______________

PETITION OF:

 

Name:

District/Address:

Date Added:

Thomas A. Golden, Jr.

16th Middlesex

1/20/2011

Martin J. Walsh

13th Suffolk

2/3/2011


HOUSE DOCKET, NO. 2198        FILED ON: 2/18/2011

HOUSE  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  No. 3364

By Mr. Golden of Lowell, a petition (accompanied by resolve, House, No. 3364) of Thomas A. Golden, Jr. and Martin J. Walsh for an investigation by a special commission (including members of the General Court) relative to responsible practices in issuing prescriptions.  Public Health.

 

The Commonwealth of Massachusetts

 

_______________

In the Year Two Thousand Eleven

_______________

 

Resolve An Act relative to responsible prescription prescribing.

 

Resolved, There is hereby established a special commission to investigate responsible prescription practices in Massachusetts.  The commission shall consist of 3 members of the house of representatives, 1 of whom shall be appointed by the minority leader of the house of representatives; 3 members of the senate, 1 of whom shall be appointed by the minority leader of the Senate; 1 representative from the executive office for administration and finance; the commissioner of public health drug control program or the commissioner's designee; the director of the prescription monitoring program or the director's designee; and 3 members appointed by the governor that represent the medical and pharmaceutical community with specialty experience in drug regulation, prescription, treatment and abuse. The commission's investigation, shall include, but not be limited to best practices for responsible prescription. The commission shall submit a report of its findings, including legislative recommendations, if any, to the joint committee on public health and the house and senate committees on ways and means by April 15, 2012.